DHRS9 重组蛋白, Human (His)

DHRS9 Protein, Human, Recombinant (His)

产品编号 TMPY-03859

Dehydrogenase/reductase (SDR family) member 9 (DHRS9) is aberrantly expressed in colorectal cancer (CRC), the decreased expression of DHRS9 correlates with tumor progression and may serve as a potential prognostic biomarker in CRC. The human regulatory macrophage (Mreg) has emerged as a promising cell type for use as a cell-based adjunct immunosuppressive therapy in solid organ transplant recipients. DHRS9 is a specific and stable marker of human Mregs.

DHRS9 Protein, Human, Recombinant (His)

产品编号 TMPY-03859

规格	价格	库存	数量
100 μg	¥ 4,460	5日内发货

大包装 & 定制

加入购物车

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

常见问题解答

问小规格产品，收到瓶子后看不到任何东西？

答由于产品规格小，粉末在运输过程中产生的静电导致过于分散，管壁和盖子上皆会粘着，您可以放心，离心后加入适量溶剂直接配制母液、充分溶解即可。

问抑制剂产品应如何储存？

答粉末储存在 -20℃，可以存 3 年以上。母液一般储存于 -80℃，可以存 1 年以上，建议多分装几管，避免反复冻融。常用的存于 4℃，可放一周以上。

问收到化合物后，是否需要称量后配制储备液？

答对于小包装，如 1 mg、5 mg、10 mg 等，不建议二次称量。这样会导致化合物损耗，且无法估算。TargetMol 所有产品原装进口，精准称量，您收到后可直接添加相应量溶剂。对于大包装，如果您需要分批次实验，可每次称量后配制储备液，建议您 10 mg 起称，称量的误差会小一些；当然条件允许，也可以先配制成高浓度母液，分装备用。

问超声一般需要多久？

答超声时长和溶解的量和浓度都有关，一般建议半个小时左右，如果浓度接近最大溶解度，或者需溶解的粉末较多，建议延长超声时间，并辅以加热。

问超声久了会不会对化合物的结构有影响？

答建议以较低频率对化合物进行超声，不会对化合物的结构造成影响。

产品信息

生物活性	Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first.
产品描述	Dehydrogenase/reductase (SDR family) member 9 (DHRS9) is aberrantly expressed in colorectal cancer (CRC), the decreased expression of DHRS9 correlates with tumor progression and may serve as a potential prognostic biomarker in CRC. The human regulatory macrophage (Mreg) has emerged as a promising cell type for use as a cell-based adjunct immunosuppressive therapy in solid organ transplant recipients. DHRS9 is a specific and stable marker of human Mregs.
种属	Human
表达系统	E. coli
标签	N-His
蛋白编号	Q9BPW9-1
别名	SDR9C4,RETSDR8,RDH-TBE,RDHTBE,RDHL,RDH-E2,RDH15,dehydrogenase/reductase (SDR family) member 9,3α-HSD,3-α-HSD,3ALPHA-HSD,3-alpha-HSD
蛋白构建	A DNA sequence encoding the human DHRS9 (NP_005762.2) (Arg18-Val319) was expressed with a polyhistidine tag at the N-terminus. Predicted N terminal: His
蛋白纯度	> 90 % as determined by SDS-PAGE
分子量	35.5 kDa (predicted); 34 kDa (reducing conditions)
内毒素	Please contact us for more information.
缓冲液	Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.4. Typically, a mixture containing 5% to 8% trehalose, mannitol, and 0.01% Tween 80 is incorporated as a protective agent before lyophilization.
复溶方法	A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information.
存储	It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
运输方式	In general, Lyophilized powders are shipping with blue ice.
研究背景	Dehydrogenase/reductase (SDR family) member 9 (DHRS9) is aberrantly expressed in colorectal cancer (CRC), the decreased expression of DHRS9 correlates with tumor progression and may serve as a potential prognostic biomarker in CRC. The human regulatory macrophage (Mreg) has emerged as a promising cell type for use as a cell-based adjunct immunosuppressive therapy in solid organ transplant recipients. DHRS9 is a specific and stable marker of human Mregs.

DHRS9 Protein, Human, Recombinant (His)

DHRS9 Protein, Human, Recombinant (His)

产品信息

SCI 文献

计算器

技术支持

关键词